This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. While we agree with the authors regarding the benefit of multiple layers of amniotic membrane transplantation (AMT) in faster healing of shield ulcer, we have certain doubts regarding the technique.
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The authors have described that the first amniotic membrane was applied with stromal side up with margins tucked in the subepithelial pockets created in the surrounding de-epithelized edges and the second membrane was put with the stromal side down. [1] We would like to ask the authors about how the stromal side up type of AMT would have lead to rapid epithelial healing. It is the basement membrane (BM) of amniotic membrane which promotes migration, adhesion, and differentiation of surrounding epithelial cells, and therefore, AMT should be done with the epithelium or BM side up when used as a graft in persistent epithelial defects or nonhealing ulcers. [2, 3] The stromal side of amniotic membrane inhibits the fibroblastic proliferation by inhibiting the TGF-B signaling pathway and should be placed towards conjunctival or corneal side when used for reducing the scarring. [4] It also reduces inflammation by acting as a barrier to the toxic effects of tears when used as a patch. [5] We are also of the same opinion that when used as a graft it should be put with BM side up, and when used as a patch, it should be put with the stromal side down.
Besides we would also like to ask the opinion of authors about their experience of topical immunosuppressants (tacrolimus, cyclosporine, etc.) in such cases of severe vernal keratoconjunctivities.
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In shield ulcer, the main cause of epithelial defect is mechanical (papillae) along with chemical mechanism (eosinophillic major basic protein). [2] Thus, the primary aim of performing amniotic membrane graft (AMG) was to provide mechanical protection to the growing epithelium. Hence, we believe keeping the basement membrane (BM) side up or down would not make that much difference in such cases.
The inner layer acting as a graft has the purpose of filling-in the defect and replaces the absent stromal matrix, which it can efficiently do with BM down also. [3] In addition, the AMG with BM down can still provide the growth factors by the mechanism of diffusion or dispersion to the surrounding growing epithelium.
Lastly, inflammation rather than growth factor deficiency is the main culprit in shield ulcer. The stromal matrix of AMG has several ways to reduce the local inflammation. These include suppression of the inflammatory signaling factors; entrapment of inflammatory cells (e.g., eosinophils and the EMBP that plays central role in pathogenesis of shield ulcer) from other tissues and rapid induction of apoptosis of inflammatory cells. [4] Thus, the stroma reduces inflammation locally and keeping it up towards the growing epithelium may prevent the exposure to inflammatory mediators and hasten shield ulcer healing.
However, we cannot say conclusively that the technique we followed is 100% perfect. To define the ideal orientation of AM in shield ulcer, one has to conduct some controlled trial.
We agree with the authors that the AMG should be done with stroma side up when used as a patch in persistent epithelial defects or non-healing ulcers to provide growth factors, which would promote epithelial healing.
[1] But as we have clarified in the above discussion, the purpose of AMG was different in our cases.
Regarding our experience with topical immunosuppressants (tacrolimus and cyclosporine) in such cases of severe vernal keratoconjunctivities, we would like to add that both of these agents are effective. However, there are still some unanswered questions such as optimal duration, dose/frequency and indications of their use. Currently we are using them as steroid sparing agents only.
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